Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin+Sitagliptin”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01106690
What this trial is testing

The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 344
Large-scale testing (Phase 3)Study completedNCT00106704
What this trial is testing

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 441
Large-scale testing (Phase 3)Study completedNCT00350779
What this trial is testing

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 262
Not applicableStudy completedNCT07763899
What this trial is testing

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.

Who this might be right for
Bioequivalance
ADIUM 46
Post-approval studies (Phase 4)UnknownNCT02480465
What this trial is testing

Efficacy and Safety of Lobeglitazone Versus Sitagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 248
Post-approval studies (Phase 4)Study completedNCT01709305
What this trial is testing

The Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 5,570
Large-scale testing (Phase 3)Study completedNCT00541450
What this trial is testing

Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 492
Large-scale testing (Phase 3)Study completedNCT00337610
What this trial is testing

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC 190
Large-scale testing (Phase 3)Study completedNCT01841697
What this trial is testing

Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 642
Early research (Phase 1)UnknownNCT06233240
What this trial is testing

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

Who this might be right for
Healthy Subjects
Bio-innova Co., Ltd 34
Post-approval studies (Phase 4)Study completedNCT01490918
What this trial is testing

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Who this might be right for
Type 2 Diabetes Mellitus
The Catholic University of Korea 165
Large-scale testing (Phase 3)Study completedNCT01930188
What this trial is testing

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,231
Early research (Phase 1)Study completedNCT00975052
What this trial is testing

The Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 16
Large-scale testing (Phase 3)Study completedNCT00984867
What this trial is testing

Dapagliflozin DPPIV Inhibitor add-on Study

Who this might be right for
Type 2 Diabetes
AstraZeneca 833
Post-approval studies (Phase 4)Study completedNCT00969566
What this trial is testing

Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination

Who this might be right for
Diabetes
Seoul National University Bundang Hospital 150
Post-approval studies (Phase 4)Study completedNCT00751114
What this trial is testing

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 515
Testing effectiveness (Phase 2)Study completedNCT03359590
What this trial is testing

Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients

Who this might be right for
Pharmacological Action
Profil Institut für Stoffwechselforschung GmbH 20
Post-approval studies (Phase 4)Study completedNCT00870194
What this trial is testing

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 255
Large-scale testing (Phase 3)Study completedNCT00103857
What this trial is testing

MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,208
Post-approval studies (Phase 4)Study completedNCT01856907
What this trial is testing

Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

Who this might be right for
Disorder of Glucose Regulation
Woman's 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation